UPDATED Apr 24, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TFC | US$38.79 | 8.8% | 26.8% | US$52.0b | US$42.52 | PB1x | E64.4% | 5.4% | Banks | ||
IVZ | US$14.52 | -4.7% | -14.3% | US$6.6b | US$16.91 | PS1.1x | E32.1% | 5.6% | Diversified Financials | ||
BANC | US$14.09 | 2.0% | n/a | US$2.3b | US$17.13 | PB0.8x | E149.1% | 2.8% | Banks | ||
SMAR | US$38.36 | 1.8% | -6.5% | US$5.3b | US$49.28 | PS5.5x | E50.5% | n/a | Software | ||
EBC | US$13.13 | 7.3% | 19.0% | US$2.1b | US$16.50 | PB0.7x | E95.5% | 3.4% | Banks | ||
ACAD | US$16.59 | -3.5% | -18.3% | US$2.8b | US$29.09 | PS3.8x | E40.9% | n/a | Pharmaceuticals & Biotech | ||
RAMP | US$32.36 | 1.9% | 40.3% | US$2.2b | US$47.75 | PS3.4x | E176.3% | n/a | Software | ||
ENOV | US$56.17 | -0.1% | -1.1% | US$3.0b | US$75.20 | PS1.8x | E83.1% | n/a | Healthcare | ||
ZETA | US$12.28 | 3.6% | 25.9% | US$2.6b | US$15.35 | PS3.7x | E107.3% | n/a | Software | ||
SYM | US$40.25 | -4.1% | 36.9% | US$23.5b | US$54.27 | PS2.9x | E115.8% | n/a | Capital Goods | ||
AXSM | US$71.17 | 2.1% | 1.5% | US$3.5b | US$121.13 | PS12.5x | E60.7% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$17.78 | -4.4% | 114.7% | US$2.9b | US$26.36 | PS17.7x | E123.6% | n/a | Semiconductors | ||
ZS | US$177.46 | 2.6% | 90.7% | US$26.5b | US$258.52 | PS14x | E41.1% | n/a | Software | ||
HIMS | US$12.34 | -0.6% | 10.3% | US$2.6b | US$14.94 | PS3x | E44.9% | n/a | Healthcare | ||
CLBT | US$10.71 | 3.2% | 100.2% | US$2.2b | US$13.64 | PS7.1x | E55.5% | n/a | Software | ||
SPB | US$81.19 | 2.6% | 27.3% | US$2.4b | US$92.79 | PB1.1x | E50.8% | 2.1% | Household | ||
EXAS | US$63.24 | 0.03% | 0.9% | US$11.5b | US$89.37 | PS4.6x | E61.9% | n/a | Pharmaceuticals & Biotech | ||
PTVE | US$15.25 | 7.1% | 107.2% | US$2.7b | US$16.86 | PB2x | E74.3% | 2.6% | Materials | ||
BECN | US$97.21 | 4.3% | 69.8% | US$6.2b | US$108.92 | PB3.4x | E61.1% | n/a | Capital Goods | ||
GLBE | US$33.53 | 0.3% | 20.1% | US$5.6b | US$44.07 | PS9.8x | E89.9% | n/a | Retail | ||
QRVO | US$112.15 | 2.0% | 24.9% | US$10.4b | US$115.80 | PS3.1x | E68.7% | n/a | Semiconductors | ||
ITCI | US$73.12 | -4.7% | 19.8% | US$7.7b | US$90.28 | PS16.4x | E57.6% | n/a | Pharmaceuticals & Biotech | ||
BIO | US$278.21 | -4.3% | -36.2% | US$8.1b | US$428.90 | PS3x | E81.3% | n/a | Pharmaceuticals & Biotech | ||
NYCB | US$3.06 | 3.0% | -66.0% | US$2.5b | US$4.91 | PB0.3x | E92.9% | 6.5% | Banks |